[HTML][HTML] Listeria monocytogenes: a promising vector for tumor immunotherapy
YD Ding, LZ Shu, RS He, KY Chen, YJ Deng… - Frontiers in …, 2023 - frontiersin.org
Cancer receives enduring international attention due to its extremely high morbidity and
mortality. Immunotherapy, which is generally expected to overcome the limits of traditional …
mortality. Immunotherapy, which is generally expected to overcome the limits of traditional …
[HTML][HTML] Listeria monocytogenes: a promising vector for tumor immunotherapy
YD Ding, LZ Shu, RS He, KY Chen, YJ Deng… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Cancer receives enduring international attention due to its extremely high morbidity and
mortality. Immunotherapy, which is generally expected to overcome the limits of traditional …
mortality. Immunotherapy, which is generally expected to overcome the limits of traditional …
Listeria monocytogenes: a promising vector for tumor immunotherapy.
YD Ding, LZ Shu, RS He, KY Chen, YJ Deng… - Frontiers in …, 2023 - europepmc.org
Cancer receives enduring international attention due to its extremely high morbidity and
mortality. Immunotherapy, which is generally expected to overcome the limits of traditional …
mortality. Immunotherapy, which is generally expected to overcome the limits of traditional …
Listeria monocytogenes: a promising vector for tumor immunotherapy
YD Ding, LZ Shu, RS He, KY Chen… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Cancer receives enduring international attention due to its extremely high morbidity and
mortality. Immunotherapy, which is generally expected to overcome the limits of traditional …
mortality. Immunotherapy, which is generally expected to overcome the limits of traditional …